Tisch MS Center's FDA-Approved Phase I Stem Cell Trial for …

REPAIR, REGENERATE & RENEW: Cutting-Edge Stem Cell Research at Tisch MS Research Center of New York

In 2013, Tisch MSRCNY made stem cell science history.

Our adult stem cell treatment received FDA approval for a Phase I Clinical Trial that has the potential to repair the damage caused by MS.

This exciting milestone took over ten years to reach and brings indescribable hope to MS patients and their loved ones all over the world.

Our stem cell therapy is the star of the research program at the Tisch MS Research Center of New York (Tisch MSRCNY), a 501(c)(3), independent, non-profit research center dedicated to finding the cause of and cure for multiple sclerosis (MS). The Center focuses on patient-based research, bringing findings rapidly from the laboratory into clinical application to treat symptoms of MS and to halt or reverse damage caused by the disease.

From our preclinical models, we know that stem cells injected into the spinal fluid can have significant benefit in terms of improved neurological symptoms.

Continue reading here:
Tisch MS Center's FDA-Approved Phase I Stem Cell Trial for ...